This Board consists of experts in the fields of oncology, pharmacology, natural products, drug discovery and development, traditional Chinese medicine, acupuncture, and homeopathy. The Board also contains representatives from the cancer patient community. This Editorial Board meets quarterly to write and update information summaries on complementary and alternative therapies for cancer.
- Jeffrey White, M.D., Editor-in-Chief
National Cancer Institute
Rockville, MD - Donald I. Abrams, M.D.
UCSF Osher Center for Integrative Medicine
San Francisco, CA - Lawrence Berk, M.D., Ph.D.
University of South Florida
Tampa FL - John A. Beutler, Ph.D.
National Cancer Institute
Frederick, MD - Keith Block, M.D.
Block Center for Integrative Cancer Treatment
Skokie, IL - John Boik Ph.D.
New Earth Biomed
Irvine, CA - Gordon M. Cragg, Ph.D.
Bethesda, MD - Jinhui Dou, Ph.D.
Food and Drug Administration
Rockville, MD - Wayne B. Jonas, M.D.
Samueli Institute
Alexandria, VA - Kara Kelly, M.D.
Columbia University
New York, NY
| - Douglas Kinghorn, Ph.D., D.Sc.
Ohio State University
Columbus, OH - Nagi B. Kumar, Ph.D., R.D., FADA
Moffitt Cancer Center
Tampa, FL - Elena J. Ladas, M.S., R.D.
Columbia University
New York, NY - Neal Paul Levitan
Community Advocate
Cambridge, MA - Tieraona Low Dog, M.D.
Arizona Center for Integrative Medicine
Tucson, AZ - Patrick J. Mansky, M.D.
The Cancer Team at Bellin Health
Green Bay, WI - Guido F. Pauli, PharmD, Ph.D.
University of Illinois at Chicago
Chicago, IL - Carl Douglas Rogers
Patient Advocate
Los Angeles, CA - Xiaoming Tian, M.D., L.Ac.
Academy of Acupuncture & Chinese Medicine
Bethesda, MD
|
